Delivery of extracellular vesicle-associated microRNA-146a regulates human monocyte phenotype and function

Area of Science:

• Immunology
• Cardiovascular Biology
• Extracellular Vesicles

Background:

• Monocyte recruitment via CCR2 is crucial for myocardial repair but can lead to adverse remodeling if prolonged.
• CCR2 inhibition is a potential therapeutic strategy for myocardial injury.
• Cardiosphere-derived cell extracellular vesicles (CDC-EVs) exhibit cardioprotective properties, partly via immune modulation.

Purpose of the Study:

• To investigate if CDC-EVs regulate inflammatory monocyte trafficking by affecting CCR2 signaling.
• To elucidate the mechanism by which CDC-EVs influence monocyte behavior.

Main Methods:

• Human monocytes were treated with CDC-EVs.
• CCR2 surface expression was analyzed.
• Monocyte migration assays towards CCL2 were performed.
• The role of miR-146a was assessed.

Main Results:

• CDC-EVs significantly reduced CCR2 surface expression on human monocytes.
• This reduction was dependent on an miR-146a mechanism.
• CDC-EV treatment led to decreased monocyte migration in response to CCL2.

Conclusions:

• CDC-EVs modulate CCR2-dependent monocyte trafficking through an miR-146a-dependent mechanism.
• This represents a novel pathway for EV-mediated regulation of innate immune responses in myocardial injury.
• CDC-EVs hold therapeutic potential for managing inflammatory responses post-myocardial injury.